Bates, Janine; Francis, Nick A.; White, Patrick; Gillespie, David; Thomas-Jones, Emma; Breen, Rachel; Kirby, Nigel; Hood, Kerry; Gal, Micaela; Phillips, Rhiannon; Naik, Gurudutt; Cals, Jochen; Llor, Carl; Melbye, Hasse; Wootton, Mandy; Riga, Evgenia; Cochrane, Ann; Howe, Robin; Fitzsimmons, Deborah; Sewell, Bernadette; Alam, Mohammed Fasihul; Butler, Christopher C. (Journal article; Tidsskriftartikkel; Peer reviewed, 2017-09-29)
Background: <br>Most patients presenting with acute exacerbations of chronic obstructive pulmonary disease (AECOPD)
in primary care are prescribed an antibiotic, which may not always be appropriate and may cause harm. C-reactive
protein (CRP) is an acute-phase biomarker that can be rapidly measured at the point of care and may predict benefit
from antibiotic treatment in AECOPD. It is not clear ...